Sector: Health Care.Industry: Pharmaceuticals
Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is engaged in the research and development of novel anti-infective agents to treat serious infections, with a focus on the pleuromutilin class of antibiotics. The company is developing product candidate, lefamulin, to be the first pleuromutilin antibiotic available for systemic administration in humans. It operates in one reportable segment, which comprises the research and development of novel anti-infective agents to treat serious infections.
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBRV | Nabriva Therapeutics | 0% | 57.7M |
Nabriva Therapeutics Company Questions & Answers
Q
How do I buy Nabriva Therapeutics (NBRV) stock?
A
You can purchase shares of Nabriva Therapeutics (NASDAQ: NBRV) through any online brokerage.
Q
Who are Nabriva Therapeutics's (NBRV) main competitors?
A
Other companies in Nabriva Therapeutics’s space includes: Teligent (NASDAQ:TLGT), Baudax Bio (NASDAQ:BXRX) and Cumberland (NASDAQ:CPIX).
Q
What is the target price for Nabriva Therapeutics?
A
There is no analysis for Nabriva Therapeutics
Q
How much is Nabriva Therapeutics (NBRV) stock ?
A
The stock price for Nabriva Therapeutics (NASDAQ: NBRV) is $1.66 last updated Fri Apr 09 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
Q
When is the next Nabriva Therapeutics (NBRV) dividend?
A
There are no upcoming dividends for Nabriva Therapeutics.
Q
When is Nabriva Therapeutics (NASDAQ:NBRV) reporting earnings?
A
There are no earnings for Nabriva Therapeutics
Q
When is the upcoming split for NBRV?
A
There is no upcoming split for Nabriva Therapeutics.